Clinical Trials Directory

Trials / Unknown

UnknownNCT06269731

Anxiety & Depression in Thyroid Cancer Patients

Anxiety, Depression and Quality of Life in Thyroid Cancer Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
159 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers

Summary

1. To identify the prevalence of both anxiety and depression in thyroid cancer patients 2. To assess quality of life in thyroid cancer patients

Detailed description

In recent years, increasing attention has been paid to mental health among cancer patients. Thyroid cancer is one of the most frequent endocrine neoplasia. It consists of 4 subtypes of papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer. Which is usually asymptomatic in the early stages, but symptoms such as neck pain, hoarseness, and dysphagia may occur as the disease progresses. TC is diagnosed by physical examination, analysis of thyroid hormone levels, imaging, and biopsy. Anxiety and depression are the most common psychological problems in the treatment of cancer patients and are related to the majority of medical diseases and physical symptoms. Studies have suggested that anxiety and depression are common in patients with thyroid cancer. Therefore, quality of life which includes psychological, social, and spiritual well-being, has become an important consideration . These findings highlight the importance of identifying thyroid cancer patients needs to allow better and more adequate care and support.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHamilton depression Rating Scalealso known as the Ham-D is the most widely used clinician-administered depression assessment scale. The original version contains 17 items (HDRS17) pertaining to symptoms of depression experienced over the past week. Although the scale was designed for completion after an unstructured clinical interview, The scale has been translated into a number of languages including French, German, Italian, Thai , Turkish and Arabic version by Mostafa Lotfy.

Timeline

Start date
2024-03-01
Primary completion
2025-12-01
Completion
2026-03-01
First posted
2024-02-21
Last updated
2024-02-21

Source: ClinicalTrials.gov record NCT06269731. Inclusion in this directory is not an endorsement.